135 related articles for article (PubMed ID: 19574771)
1. Primary psammocarcinoma of the ovary or peritoneum.
Poujade O; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
Int J Gynecol Cancer; 2009 Jul; 19(5):844-6. PubMed ID: 19574771
[TBL] [Abstract][Full Text] [Related]
2. Secondary surgery in patients with serous low malignant potential ovarian tumors with peritoneal implants.
Kane A; Uzan C; Rey A; Gouy S; Duvillard P; Morice P
Int J Gynecol Cancer; 2010 Apr; 20(3):346-52. PubMed ID: 20375795
[TBL] [Abstract][Full Text] [Related]
3. [Results of cytoreductive surgery for advanced and recurrent ovarian neoplasms and papillary serous carcinomas of the peritoneum].
Ivanov S; Ivanov S
Akush Ginekol (Sofiia); 2004; 43(5):36-8. PubMed ID: 15518283
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with advanced-stage borderline ovarian tumors after a first peritoneal noninvasive recurrence: impact on further management.
Uzan C; Zanini-Grandon AS; Bentivegna E; Gouy S; Leary A; Duvillard P; Morice P
Int J Gynecol Cancer; 2015 Jun; 25(5):830-6. PubMed ID: 25828751
[TBL] [Abstract][Full Text] [Related]
5. Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study.
Luyckx M; Leblanc E; Filleron T; Morice P; Darai E; Classe JM; Ferron G; Stoeckle E; Pomel C; Vinet B; Chereau E; Bergzoll C; Querleu D
Int J Gynecol Cancer; 2012 Oct; 22(8):1337-43. PubMed ID: 22964527
[TBL] [Abstract][Full Text] [Related]
6. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
[TBL] [Abstract][Full Text] [Related]
7. Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG-G1402).
Hirakawa T; Minaguchi T; Itani Y; Kasamatsu Y; Murase S; Sakurada S; Nagano H; Takehara K; Tsuruta T; Arakawa A; Kawano K; Tsubamoto H; Ushiwaka T; Mori T; Iwai K; Saito M; Morisawa H; Saito F; Yoshida K; Kaneuchi M; Sato H; Ito K; Nasu K
World J Surg Oncol; 2017 Jul; 15(1):132. PubMed ID: 28716033
[TBL] [Abstract][Full Text] [Related]
8. Aggressive ovarian psammocarcinoma: a case report.
Zakkouri FA; Berrada N; Kettani F; Mrabti H; Jalil A; Errihani H
Eur J Gynaecol Oncol; 2011; 32(2):214-5. PubMed ID: 21614920
[TBL] [Abstract][Full Text] [Related]
9. Conservative surgery in a young patient with peritoneal psammocarcinoma.
Munkarah AR; Jacques SM; Qureshi F; Deppe G
Gynecol Oncol; 1999 May; 73(2):312-4. PubMed ID: 10329052
[TBL] [Abstract][Full Text] [Related]
10. International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer.
Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Peregrin I; Mendizabal E; Ortiz-Quintana L
Int J Gynecol Cancer; 2015 Jan; 25(1):49-54. PubMed ID: 25405578
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic tumor spreading in primary ovarian cancer with modified posterior exenteration.
Kato K; Nishikimi K; Tate S; Kiyokawa T; Shozu M
World J Surg Oncol; 2015 Jul; 13():230. PubMed ID: 26228239
[TBL] [Abstract][Full Text] [Related]
12. Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation.
Fotopoulou C; Zang R; Gultekin M; Cibula D; Ayhan A; Liu D; Richter R; Braicu I; Mahner S; Harter P; Trillsch F; Kumar S; Peiretti M; Dowdy SC; Maggioni A; Trope C; Sehouli J
Ann Surg Oncol; 2013 Apr; 20(4):1348-54. PubMed ID: 23054114
[TBL] [Abstract][Full Text] [Related]
13. Ovarian psammocarcinoma with peritoneal implants.
Cobellis L; Pezzani I; Cataldi P; Bome A; Santopietro R; Petraglia F
Eur J Obstet Gynecol Reprod Biol; 2003 Apr; 107(2):217-9. PubMed ID: 12648875
[TBL] [Abstract][Full Text] [Related]
14. Successful pregnancy after fertility-sparing surgery for peritoneal psammocarcinoma: a case report.
Shah JP; Bryant CS; Kumar S; Ali-Fehmi R; Morris RT
J Reprod Med; 2009 Mar; 54(3):179-83. PubMed ID: 19370904
[TBL] [Abstract][Full Text] [Related]
15. Primary peritoneal serous psammocarcinoma with recurrent disease and metastasis: a case report and review of the literature.
Akbulut M; Kelten C; Bir F; Soysal ME; Duzcan SE
Gynecol Oncol; 2007 Apr; 105(1):248-51. PubMed ID: 17222893
[TBL] [Abstract][Full Text] [Related]
16. Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index.
Llueca A; Serra A; Rivadulla I; Gomez L; Escrig J;
World J Surg Oncol; 2018 Feb; 16(1):37. PubMed ID: 29471831
[TBL] [Abstract][Full Text] [Related]
17. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
18. Ovarian serous borderline tumors with invasive peritoneal implants.
Gershenson DM; Silva EG; Levy L; Burke TW; Wolf JK; Tornos C
Cancer; 1998 Mar; 82(6):1096-103. PubMed ID: 9506355
[TBL] [Abstract][Full Text] [Related]
19. Psammocarcinoma with an aggressive course.
Poggi SH; Bristow RE; Nieberg RK; Berek JS
Obstet Gynecol; 1998 Oct; 92(4 Pt 2):659-61. PubMed ID: 9764653
[TBL] [Abstract][Full Text] [Related]
20. Serous ovarian and primary peritoneal cancers: A comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome.
Gao B; Lindemann K; Anderson L; Fereday S; Hung J; Alsop K; Tothill RW; Gebski V; Kennedy C; Balleine RL; ; Harnett PR; Bowtell DD; DeFazio A
Gynecol Oncol; 2016 Sep; 142(3):458-64. PubMed ID: 27444035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
